“showed a trend”

acris because heavier seeds showed a trend for earlier flowering and a more vigorous branching pattern, which led to higher fecundity.

Further analysis was performed to compare plasma anti-HER2 IgG levels between subgroups and indicated that anti-HER2 IgG levels were slightly lower in patients with oral benign tumor and early stage OSCC than control subjects, while plasma anti-HER2 IgG levels showed a trend toward an increase in OSCC patients at the middle & advanced stages compared with those at the early stage ( Table 2 ).

In the BAL from LPS-challenged mice, treatment with ACT-1004-1239 significantly reduced LPS-induced CXCR3 + lymphoid cell recruitment ( Figure 3C ) and showed a trend to decrease the late recruitment of the few CXCR3 + myeloid cells induced by LPS, although this did not reach statistical significance ( Figure 3D ).

The RSCU values of the PCGs showed a trend toward the use of A/T compared with that of G/C.

In recent years, the incidence rate has increased yearly, and it has showed a trend of being diagnosed in younger people.

Moreover, LIPA and COL1A2 expression showed a trend towards increasing in parallel with the degree of disease activity, with some significant intergroup differences when NAFLD cases were stratified according to NAS score (Fig. 5 E).

The male mice displayed high variability in both FMN and FAD concentrations, and only the CerS6 KO brains showed a trend for increasing mean cofactor concentrations with increase in dietary FA, which is opposite to the effect observed in the liver.

The study showed a trend toward higher composite all-cause mortality and amputations in the paclitaxel DCB group compared with PTA but this difference did not reach statistical significance (35.2 vs. 25.2%, P = 0.064).

Nonetheless, posterior ETT showed a trend for a higher risk of failure than anterior ETT (adjusted HR = 1.68, 95% CI 0.81–3.45; Table 3 ).

Our meta-analysis of these studies showed a trend toward lower odds of completing a university degree, secondary education, or vocational training.

11 Following a phase I dose‐escalation safety study, a 60‐subject, multisite phase IIa clinical trial showed that PACT‐produced MSCs were well‐tolerated and showed a trend for improvement in oxygenation index in the treated group. 12 A phase IIb trial jointly supported by the Department of Defense and PACT 3/NHLBI is underway at the time of writing this manuscript.

Despite not significant, the rates of women undergoing IOL showed a trend of increase in the group 2 (25.5% versus 38.2%, P : 0.137).

The therapy group showed a trend toward the lowest number of Ki67-positive cells ( Figure 6 E) and a significantly smaller area of CD31 positivity ( Figure 6 F) compared with the control groups.

Heterosexual women showed a trend of larger pupil sizes during the viewing of other-sex (i.e., male) stimuli, but the magnitude of this effect was small and not significant.

PAR1 inhibition by SCH79797 showed wider effects in CD8 T cell function including inhibition of IFNγ secretion and showed a trend in TNFα secretion although it did not reach statistical significance ( Figure S2 F).

Compared to untreated patients, all patients treated with BTA showed a trend towards suppression of bone formation, as measured by tetracycline labelling.

Cerebral infarction showed a trend to higher levels than the pre-pandemic period in the final months of the study period (Fig. 6 , Supplementary Fig. 1 ).

Adult patients who were subsequently prescribed rhPTH(1-84) showed a trend for higher numbers of doctors’ office visits and ED visits in the 12 months before baseline versus those who received conventional therapy (Table 7 ).

In the first dataset of BLAZE-1, bamlanivimab showed a trend towards decreased viral load vs. placebo with a significant difference for the 2800-mg dose [ 30 ].

In contrast, remdesivir use showed a trend to lower mortality risk (aHR, 0.48; 95% CI, 0.23–1.02) ( Figure 1 ).

Regarding survival, even if treatments and follow-up are still ongoing in 17 patients, our study showed a trend in PFS and OS comparable to those of previous cemiplimab trials with long duration of response.

The prognostic significance of BRCA1 expression showed a trend in multivariate analysis (HR: 0.21, 95% CI: 0.04 – 1.11) ( Table 2 ).

Cav-1 KO mice showed a trend toward increased superficial capillary plexus vessel density and branching density in all regions compared to WT, however, only branching density in the mid-region showed a statistically significant difference.

Furthermore, our data showed a trend toward lower objective tumor responses and disease control rates among patients who received lower pre-emptive nal-IRI dosing.

But the EE group showed a trend of recovery in all indexes compared to the M group.